XBIO - Xenetic Biosciences, Inc.

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
5.12 -0.22 (-4.3%)	---	---	---	0.13 (2.54%)	-0.31 (-6.05%)	0.09 (1.87%)	0.09 (1.87%)

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.45
Diluted EPS:: -0.45
Basic P/E:: -10.8889
Diluted P/E:: -10.8889
RSI(14) 1m:: 0.0
VWAP:: 4.9
RVol:: 0.0781

Events

Period	Kind	Movement	Occurred At
10m	Price decrease 10m	4.57 -0.15 (-3.27%)	Oct 15 14:37
Day	Price decrease day	4.61 -0.51 (-10.06%)	Oct 15 14:36
1m	Price decrease 1m	4.65 -0.07 (-1.48%)	Oct 15 14:35
60m	Price decrease 60m	4.75 -0.25 (-5.0%)	Oct 15 13:20
10m	Price decrease 10m	4.84 -0.17 (-3.3%)	Oct 15 13:09